The risk that revisions to pharmaceutical and medical device regulations, including approval, licensing and monitoring systems and drug pricing systems, will affect the development, sales and earnings environment for pharmaceuticals and medical devices. Covers regulatory changes spanning both pharmaceuticals and medical devices.